Literature DB >> 24060571

Vitamin D deficiency in first episode psychosis: a case-control study.

Matthieu Crews1, John Lally, Poonam Gardner-Sood, Oliver Howes, Stefania Bonaccorso, Shubulade Smith, Robin M Murray, Marta Di Forti, Fiona Gaughran.   

Abstract

BACKGROUND: Vitamin D deficiency is seen in a high proportion of people with established psychotic disorders, but it is not known if this is present at onset of the illness. We set out to examine vitamin D levels in people with their first episode of psychosis (FEP).
METHOD: We conducted a matched case-control study to examine vitamin D levels and rates of vitamin D deficiency in sixty nine patients presenting with their FEP and sixty nine controls matched for age, sex and ethnicity. Differences between groups were tested using student's-t tests, paired t-tests and odds ratios for further analysis.
RESULTS: Vitamin D levels were significantly lower in cases than in controls (p<0.001). The odds ratio of being vitamin D deficient was 2.99 in the FEP group relative to the control group. There was no correlation between vitamin D levels and length of hospitalisation in the patient group (r=-0.027, p=0.827).
CONCLUSIONS: We found higher rates of vitamin D deficiency in people with FEP compared to matched controls. Given that vitamin D is neuroprotective; that developmental vitamin D deficiency may be a risk factor for psychosis, and that incipient psychosis may affect lifestyle factors and diet, future studies are required to examine this association further. In the meantime, there is a need for more widespread testing of vitamin D levels in FEP and for the development of appropriate management strategies.
© 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  25-Hydroxyvitamin D; Case–control study; Ethnicity; First episode psychosis; Schizophrenia; Vitamin D deficiency

Mesh:

Substances:

Year:  2013        PMID: 24060571     DOI: 10.1016/j.schres.2013.08.036

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  25 in total

Review 1.  Vitamin supplementation in the treatment of schizophrenia.

Authors:  Hannah E Brown; Joshua L Roffman
Journal:  CNS Drugs       Date:  2014-07       Impact factor: 5.749

2.  Vitamin D insufficiency and schizophrenia risk: evaluation of hyperprolinemia as a mediator of association.

Authors:  James D Clelland; Laura L Read; Valérie Drouet; Angela Kaon; Alexandra Kelly; Karen E Duff; Robert H Nadrich; Amit Rajparia; Catherine L Clelland
Journal:  Schizophr Res       Date:  2014-04-29       Impact factor: 4.939

3.  Effect of psychotropic drug treatment on sterol metabolism.

Authors:  Željka Korade; Wei Liu; Emily B Warren; Kristan Armstrong; Ned A Porter; Christine Konradi
Journal:  Schizophr Res       Date:  2017-02-12       Impact factor: 4.939

4.  Correlation between total vitamin D levels and psychotic psychopathology in patients with schizophrenia: therapeutic implications for add-on vitamin D augmentation.

Authors:  Rabia Nazik Yüksel; Neslihan Altunsoy; Baise Tikir; Merve Cingi Külük; Kubranur Unal; Sema Goka; Cigdem Aydemir; Erol Goka
Journal:  Ther Adv Psychopharmacol       Date:  2014-12

Review 5.  Molecular substrates of schizophrenia: homeostatic signaling to connectivity.

Authors:  M A Landek-Salgado; T E Faust; A Sawa
Journal:  Mol Psychiatry       Date:  2015-09-22       Impact factor: 15.992

6.  The Relationship between Symptom Severity and Low Vitamin D Levels in Patients with Schizophrenia.

Authors:  Süheyla Doğan Bulut; Serdar Bulut; Dicle Görkem Atalan; Tonguç Berkol; Eda Gürçay; Türker Türker; Çiğdem Aydemir
Journal:  PLoS One       Date:  2016-10-27       Impact factor: 3.240

7.  The psychotropic effect of vitamin D supplementation on schizophrenia symptoms.

Authors:  Aras Neriman; Yilmaz Hakan; Ucuncu Ozge
Journal:  BMC Psychiatry       Date:  2021-06-15       Impact factor: 3.630

8.  Chronic Psychosocial Stress Impairs Bone Homeostasis: A Study in the Social Isolation Reared Rat.

Authors:  Stefania Schiavone; Maria G Morgese; Emanuela Mhillaj; Maria Bove; Angelo De Giorgi; Francesco P Cantatore; Claudia Camerino; Paolo Tucci; Nicola Maffulli; Vincenzo Cuomo; Luigia Trabace
Journal:  Front Pharmacol       Date:  2016-06-08       Impact factor: 5.810

9.  Does environmental confounding mask pleiotropic effects of a multiple sclerosis susceptibility variant on vitamin D in psychosis?

Authors:  Conrad O Iyegbe; Anita Acharya; John Lally; Poonam Gardner-Sood; Louise S Smith; Shubulade Smith; Robin Murray; Oliver Howes; Fiona Gaughran
Journal:  NPJ Schizophr       Date:  2015-10-28

10.  Clinical correlates of vitamin D deficiency in established psychosis.

Authors:  J Lally; P Gardner-Sood; M Firdosi; C Iyegbe; B Stubbs; K Greenwood; R Murray; S Smith; O Howes; F Gaughran
Journal:  BMC Psychiatry       Date:  2016-03-22       Impact factor: 3.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.